| Andrea C Chiaramonte, MD MPH | |
|
100 Mlk Jr Blvd Ste 4, Worcester, MA 01608-1209 | |
| (508) 757-0330 | |
| (508) 752-9850 |
| Full Name | Andrea C Chiaramonte |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 30 Years |
| Location | 100 Mlk Jr Blvd Ste 4, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538137310 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 159112 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Hospital | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Otolaryngology Head And Neck Surgery, Pc | 6507839438 | 10 |
News Archive
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
Allos Therapeutics, Inc. today announced that data on FOLOTYN® (pralatrexate injection) will be presented at two upcoming medical conferences: the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4-8 in Chicago, Illinois, and at the 15th Congress of the European Hematology Association (EHA), which will be held June 10-13 in Barcelona, Spain.
Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.
› Verified 7 days ago
| Entity Name | Associates In Otolaryngology Head And Neck Surgery, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225152663 PECOS PAC ID: 6507839438 Enrollment ID: O20080506000259 |
News Archive
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
Allos Therapeutics, Inc. today announced that data on FOLOTYN® (pralatrexate injection) will be presented at two upcoming medical conferences: the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4-8 in Chicago, Illinois, and at the 15th Congress of the European Hematology Association (EHA), which will be held June 10-13 in Barcelona, Spain.
Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea C Chiaramonte, MD MPH 100 Mlk Jr Blvd Ste 4, Worcester, MA 01608-1209 Ph: (508) 757-0330 | Andrea C Chiaramonte, MD MPH 100 Mlk Jr Blvd Ste 4, Worcester, MA 01608-1209 Ph: (508) 757-0330 |
News Archive
Applied DNA Sciences Inc. announced today that LineaRx, Inc., its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with Takis S.R.L. and Evvivax S.R.L., biotechnology companies focused on the discovery and development of DNA based anti-cancer vaccines for the human and animal markets, respectively.
During the "Jewels in Our Genes" study several years ago, Heather Ochs-Balcom and her team pinpointed four locations in the genome of African American women that may contain undiscovered genes that contribute to hereditary breast cancer.
Today Biogen Idec announced the company recently submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B.
Allos Therapeutics, Inc. today announced that data on FOLOTYN® (pralatrexate injection) will be presented at two upcoming medical conferences: the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), which will be held June 4-8 in Chicago, Illinois, and at the 15th Congress of the European Hematology Association (EHA), which will be held June 10-13 in Barcelona, Spain.
Dialysis treatments do not affect the heart health of kidney disease patients who have had a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). Since cardiovascular disease is the most common cause of death in kidney disease patients, the findings are good news for individuals who need the treatments.
› Verified 7 days ago
Anjali R. Mehta, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Suite 300, Worcester, MA 01608 Phone: 508-368-3103 Fax: 508-368-3104 | |
Mr. James P Hughes, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 48 Elm St, Worcester, MA 01609 Phone: 508-757-0330 Fax: 508-752-9850 | |
Jeremiah Charles Tracy, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-856-4161 Fax: 508-856-6703 | |
Mr. Min Shick Ahn, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 67 Belmont St, Ste 103, Worcester, MA 01605 Phone: 508-755-8623 Fax: 508-752-5231 | |
Dr. Melinda Thacker, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 48 Elm St, Worcester, MA 01609 Phone: 508-757-0330 | |
Frank P Fechner, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 428 Shrewsbury St, Worcester, MA 01604 Phone: 508-754-4000 Fax: 508-754-4222 | |
Dr. Michael K Murphy, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-856-4161 |